Fig 1.
Flow chart of enrolled patients with generalized myasthenia gravis in the study.
*Other diseases in the excluded patients included: Ehlers-Danlos syndrome (1 patient), severe osteoarthritis (6 patients), severe psychiatric diseases (1 patient), cancer (9 patients), other neurological diseases (19 patients). ** Patients examined in Aarhus, were primarily from outside Aarhus County.
Fig 2.
Manual muscle testing in eight muscle groups using the Medical Research Council (MRC) score in female patients with generalized myasthenia gravis.
L = left side & R = right side.
Fig 3.
Manual muscle testing in eight muscle groups using the Medical Research Council (MRC) score in male patients with generalized myasthenia gravis.
L = left side & R = right side.
Table 1.
Clinical profile and treatment of 107 patients with generalized myasthenia gravis.
Fig 4.
Muscle strength in women with generalized myasthenia gravis.
Muscle strength in eight muscle groups in myasthenic women assessed by hand-held dynamometry, expressed as percentage of mean normative values (corresponding to 100%). L = left side and R = right side. * = p<0.05, ** = p<0.005 and *** = p<0.0001.
Fig 5.
Muscle strength in men with generalized myasthenia gravis.
Muscle strength in eight muscle groups in myasthenic men assessed by hand-held dynamometry, expressed as percentage of mean normative values (corresponding to 100%). L = left side and R = right side. ** = p<0.005 and *** = p<0.0001.
Fig 6.
Influence of age and gender on muscle strength in generalized myasthenia gravis.
Total composite strength in mysthenic male and female patients under or older than age 50 years, expressed as percentage of normal strength in healthy age- and gender-matched subjects.
Table 2.
Muscle strength according to disease duration in men and women with generalized myasthenia gravis.
Fig 7.
Muscle strength in shoulder abductor muscle groups in gMG men (7A) and women (7B), classified into disease duration <5 years, 5–10 years and >10 years against treatment intensity.